The Precision Peptide Company Inc.
BPC
CNSX
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 3,850.00% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 3,850.00% | -- | -- |
| Cost of Revenue | -- | -- | 1,590.91% | -- | -- |
| Gross Profit | -- | -- | 4,400.00% | -- | -- |
| SG&A Expenses | 82.94% | 657.66% | 137.19% | 791.55% | 21.42% |
| Depreciation & Amortization | -- | -- | 16,750.00% | 10,800.00% | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 93.18% | 681.23% | 144.12% | 854.79% | -6.06% |
| Operating Income | -86.78% | -658.52% | -135.53% | -846.38% | 4.96% |
| Income Before Tax | -70.28% | -639.97% | -594.47% | -842.66% | -11.72% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -70.28% | -639.97% | -594.47% | -842.66% | -11.72% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -70.28% | -639.97% | -594.47% | -842.66% | -11.72% |
| EBIT | -86.78% | -658.52% | -135.53% | -846.38% | 4.96% |
| EBITDA | -78.45% | -650.25% | -127.21% | -826.86% | 4.93% |
| EPS Basic | 23.93% | -40.88% | -21.67% | -116.46% | 61.26% |
| Normalized Basic EPS | 23.29% | -40.71% | 57.78% | -118.37% | 61.38% |
| EPS Diluted | 23.93% | -40.88% | -21.67% | -116.46% | 61.26% |
| Normalized Diluted EPS | 23.29% | -40.71% | 57.78% | -118.37% | 61.38% |
| Average Basic Shares Outstanding | 124.16% | 425.41% | 470.63% | 334.60% | 187.90% |
| Average Diluted Shares Outstanding | 124.16% | 425.41% | 470.63% | 334.60% | 187.90% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |